On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 06/30/22
- Nevada reports May statewide gaming win up 5.71% to $1.3B
- 06/23/22
- Wynn Resorts Macau announces concession extension agreement
- 07/20/22
- Vaxart reports phase 1 clinical data on its oral tablet COVID-19 vaccine
- 07/01/22
- Vaxart provides update on proxy voting, urges stockholders to vote
- 06/30/22
- Vaxart, hVIVO sign agreement to develop first human omicron challenge model
- 06/08/22
- Vaxart announces adjournment of Annual Meeting of Stockholders
- 07/19/22
- Vale updates FY22 iron ore and copper production estimates
- 05/06/22
- Vale confirms supply deal with Tesla for low-carbon nickel
- 04/28/22
- Vale denies allegations of SEC, will defend itself 'vigorously'
- 04/28/22
- SEC charges Vale with misleading investors about safety ahead of dam collapse
RYTM Rhythm Pharmaceuticals - 07/20/22
- Rhythm Pharmaceuticals announces early access authorization for setmelanotide
- 07/18/22
- NICE recommends Rhythm's imcivree for treating obesity
- 07/12/22
- Rhythm announces interim results from Phase 2 trial of setmelanotide
- 07/08/22
- Rhythm Pharmaceuticals announces new employment inducement grants
RVMD Revolution Medicines - 07/13/22
- Revolution Medicines appoints Kim to board of directors
- 06/28/22
- Revolution Medicines announces election of Patel to board of directors
- 06/28/22
- Revolution Medicines doses first patient in Phase 1/1b trial of RMC-6236
- 03/24/22
- Revolution Medicines director buys $5.49M in common stock
- 06/28/22
- PayPal launches PayPal Business Cashback Mastercard
- 06/22/22
- PayPal announces upcoming changes to Goods & Services payments in U.S.
- 06/15/22
- PayPal introduces 'PayPal Pay Monthly' buy now, pay later offering
- 06/14/22
- Grubhub partners with PayPal, Visa for faster access to payments
- 07/19/22
- Northern Trust raises quarterly cash dividend to 75c from 70c per share
- 06/27/22
- Northern Trust announces CCAR results, plans to increase quarterly dividend
- 06/23/22
- Northern Trust creates Digital Assets and Financial Markets Group
- 06/16/22
- Northern Trust raises prime rate to 4.75% from 4.00%
- $216.46 /
+14.73 (+7.30%) - 07/19/22
- Netflix plans to spend roughly $17B on content over next few years
- 07/19/22
- Netflix plans wider rollout for paid sharing next year
- 07/19/22
- Netflix says negotiating for rights to put ads in other shows
- 07/19/22
- Netflix says business remains 'resilient'
- $61.60 /
+9.215 (+17.59%) - 07/20/22
- New Relic trading resumes
- 07/20/22
- New Relic trading halted, volatility trading pause
- 06/21/22
- Jana Partners discloses 5.3% stake in New Relic, appoints nominees to board
- 06/07/22
- New Relic up 6% to $50.59 after reaching agreement with Jana
- 07/20/22
- Nasdaq announces 3-for-1 stock split
- 07/20/22
- Nasdaq sees 2022 non-GAAP tax rate 24%-26%
- 06/29/22
- Nasdaq announces it welcomed 108 IPOs in first half of 2022
- 06/02/22
- Nasdaq enters agreement to acquire Metrio
- 07/20/22
- Merck says Phase 3 KEYNOTE-412 trial did not meet primary endpoint of EFS
- 07/18/22
- Merck to stop Phase 3 LYNK-003 trial investigating LYNPARZA
- 07/13/22
- Micron to select Athinia for data collaboration
- 07/13/22
- Merck, Orion partner on development of ODM-208
MLCO Melco Resorts & Entertainment - 06/23/22
- Studio City's gaming concessions in Macau extended to December 31
- 06/23/22
- Melco Resorts & Entertainment's gaming subconcession in Macau extended
- 06/01/22
- Macau reports May casino revenue down 68.0% to 3.34B patacas
- 07/14/22
- MGM Resorts, Bet MGM renew and expand agreement with MLB
- 07/12/22
- MGM Resorts to become Official Partner of MLB Players
- 07/08/22
- CVS Health appoints Mandadi as EVP, Chief Data, Digital, Technology Officer
- 07/20/22
- Las Vegas Sands CEO 'confident in the recovery of travel and tourism'
- 07/15/22
- New Jersey reports June gaming revenue up 2.2% to $401.5M
- 07/04/22
- Fly Intel: Top five weekend stock stories
- 07/01/22
- Macau reports June casino revenue down 62.1% to 2.48B patacas
- 07/12/22
- Juniper selected by Oil India Limited for data center, campus network upgrades
- 06/09/22
- Juniper announces partnership with XL Axiata
- 06/07/22
- Juniper, Dragos announce official joint partnership
- 05/13/22
- Juniper appoints Steve Fernandez to board of directors
- 07/20/22
- Ford to share update on Ford+ plan Thursday
- 07/18/22
- Ford says ordering opens today for 'most powerful F-150 Raptor ever'
- 07/10/22
- Fly Intel: Top five weekend stock stories
- 07/08/22
- Ford expanding recall for Expedition and Lincoln Navigator SUVs
- 05/05/22
- Datadog to acquire Hdiv Security, terms not disclosed
- 03/07/22
- Datadog director sells $25.4M in common stock
- 02/14/22
- Lone Pine takes stakes in Mastercard, Visa, exits Twitter, Meta Platforms
- 02/14/22
- Coleman's Tiger Global buys Embark, cuts Microsoft in Q4
- 07/20/22
- Capri Holdings sees forex headwinds of $300M in FY23
- 07/20/22
- Capri Holdings interested in 'fashion luxury' acquisitions
- 07/20/22
- Capri Holdings targets long-term operating margin about 20%
- 07/20/22
- Capri Holdings up 2% as revenue targets discussed during investor day
- 04/19/22
- Badger Meter expects near term unevenness
- 07/15/22
- Baker Hughes reports U.S. rig count up 4 to 756 rigs
- 07/15/22
- Baker Hughes reports U.S. rig count up 4 to 756 rigs
- 07/08/22
- Baker Hughes reports U.S. rig count up 2 to 752 rigs
- 07/08/22
- Baker Hughes reports U.S. rig count up 2 to 752 rigs
- $207.57 /
-12.745 (-5.78%) - 07/20/22
- Law firm says Biogen to pay $900M to resolve whistleblower claim
- 07/20/22
- Biogen sees utilizing portion of remaining buyback authorization through 2022E
- 07/20/22
- Biogen saw $55M headwind to FY revenue due to currency fluctuations
- 07/05/22
- Biogen says FDA accepts BLA for lecanemab under accelerated approval pathway
- 05/19/22
- Bath & Body Works sees FY inflation impact $225M-$250M
- 05/19/22
- Bath & Body Works to test new personal care line, including face and hair care
- 05/19/22
- Bath & Body Works: Overall Q1 transactions up low single digits vs. last year
- 05/16/22
- Lone Pine adds TSMC in Q1, exits KE Holdings and Adobe
- $103.97 /
-0.775 (-0.74%) - 07/12/22
- Synchronoss announces certification on Alibaba Cloud, Google Cloud
- 06/17/22
- Alibaba rises 9.6%
- 06/02/22
- Atlas Air takes delivery of first of four new Boeing 747-8 freighters
- 05/26/22
- Alibaba comments on COVID-19 resurgence in China
- 07/20/22
- Boeing, Azerbaijan Airlines sign MoU for four additional 787-8s
- 07/20/22
- Boeing invests $50M in AEI HorizonX
- 07/19/22
- Boeing, Aviation Capital Group announce order for twelve 737-8 jets
- 07/19/22
- AerCap announces order for five additional Boeing 787-9 Dreamliners
ATRA Atara Biotherapeutics - 07/12/22
- Atara Biotherapeutics not to expand sample size in ATA188 Ph2 study
- 06/05/22
- Atara announces clinical data from ongoing tab-cel European Multicenter EAP
- 05/19/22
- Atara Biotherapeutics down 14% at $4.44 after announcing end of Bayer deal
- 05/19/22
- Atara provides update on Bayer collaboration
- 07/20/22
- Abbott sees FY22 organic sales up high single digits
- 07/20/22
- Abbott reports Q2 Worldwide Medical Devices sales up 2.5% on reported basis
- 07/20/22
- Abbott: FY22 guidance includes projected COVID-19 testing-related sales of $6.1B
- 07/20/22
- Abbott reports Q2 Worldwide Diagnostics sales up 33.1% on a reported basis
- 07/12/22
- Apple announces 52 Emmy Award nominations for Apple TV+
- 07/12/22
- FTC to crack down on illegal use, sharing of sensitive data by tech companies
- 07/08/22
- NFL's Goodell says Sunday Ticket moving to streaming service
- 07/07/22
- Landsea Homes launches 'High Performance Home Program' across Florida
- 07/21/22 Stifel
- Las Vegas Sands price target raised to $50 from $46 at Stifel
- 07/21/22 Barclays
- Las Vegas Sands price target raised to $43 from $39 at Barclays
- 07/21/22 Citi
- Las Vegas Sands price target raised to $58 from $56 at Citi
- 07/21/22 Wells Fargo
- Las Vegas Sands upgraded to Overweight from Equal Weight at Wells Fargo
- 07/20/22 Truist
- MGM Resorts price target lowered to $35 from $48 at Truist
- 07/05/22 Citi
- MGM Resorts price target lowered to $56 from $59 at Citi
- 06/28/22 JMP Securities
- MGM Resorts initiated with an Outperform at JMP Securities
- 05/20/22 Deutsche Bank
- MGM Resorts price target lowered to $48 from $52 at Deutsche Bank
- 07/05/22 Citi
- Wynn Resorts price target lowered to $87.50 from $92 at Citi
- 06/29/22 Barclays
- Barclays initiates gaming sector, says Caesars best positioned
- 06/28/22 Barclays
- Wynn Resorts initiated with an Equal Weight at Barclays
- 05/11/22 Deutsche Bank
- Wynn Resorts price target lowered to $92 from $123 at Deutsche Bank
MLCO Melco Resorts & Entertainment - 07/05/22 Citi
- Melco Resorts price target lowered to $11 from $12.50 at Citi
- 05/09/22 CICC
- Melco Resorts downgraded to Market Perform from Outperform at CICC
- 05/06/22 CLSA
- Melco Resorts & Entertainment upgraded to Buy from Outperform at CLSA
- 04/12/22 Citi
- Citi opens '30-day positive Catalyst Watches' on Melco, Galaxy
- 07/18/22 Cowen
- Cowen believes Aerospace and Defense quarterly results to be mixed
- 07/15/22 Benchmark
- Boeing price target lowered to $200 from $250 at Benchmark
- 07/14/22 RBC Capital
- Boeing price target lowered to $200 from $220 at RBC Capital
- 07/13/22 JPMorgan
- Boeing price target lowered to $188 from $190 at JPMorgan
- 07/21/22 Morgan Stanley
- Subscription shift could add $1T to Apple market cap, says Morgan Stanley
- 07/20/22 JPMorgan
- China iPhone shipments better than seasonal in June, says JPMorgan
- 07/20/22 Morgan Stanley
- Apple price target trimmed to $180 at Morgan Stanley ahead of Q3 report
- 07/20/22 Wells Fargo
- Apple price target lowered to $185 from $205 at Wells Fargo
- $216.46 /
+14.73 (+7.30%) - 07/20/22 Oppenheimer
- Netflix subscriber beat unlikely to alleviate concerns, says Oppenheimer
- 07/20/22 Evercore ISI
- Evercore says market will need to see progress from Netflix for premium multiple
- 07/20/22 Morgan Stanley
- Netflix price target raised to $230 from $220 at Morgan Stanley
- 07/20/22 Wedbush
- Wedbush remains bullish on Netflix following quarterly results
- 07/21/22 RBC Capital
- Abbott price target lowered to $132 from $143 at RBC Capital
- 07/21/22 Citi
- Abbott price target lowered to $123 from $125 at Citi
- 07/18/22 BTIG
- Abbott price target lowered to $126 from $130 at BTIG
- 07/18/22 Stifel
- Abbott price target lowered to $126 from $136 at Stifel
- 07/21/22 Stephens
- Baker Hughes price target lowered to $32 from $40 at Stephens
- 07/21/22 Barclays
- Baker Hughes price target lowered to $44 from $46 at Barclays
- 07/13/22 Morgan Stanley
- Baker Hughes price target lowered to $35 from $40 at Morgan Stanley
- 07/13/22 Barclays
- Baker Hughes price target lowered to $46 from $47 at Barclays
- $207.57 /
-12.745 (-5.78%) - 07/21/22 Barclays
- Biogen price target lowered to $200 from $210 at Barclays
- 07/20/22 RBC Capital
- Biogen price target lowered to $259 from $264 at RBC Capital
- 07/20/22 Piper Sandler
- Biogen Q2 'surprisingly strong,' but 'rough waters' ahead, says Piper
- 07/20/22 Piper Sandler
- Piper adjusts Ionis' Spinraza royalties estimate following Biogen report
- 07/18/22 UBS
- Merck price target raised to $98 from $76 at UBS
- 07/12/22 H.C. Wainwright
- H.C. Wainwright says Bellus set for 'show down' against Merck's gefapixant
- 07/08/22 Morgan Stanley
- Merck price target raised to $88 from $87 at Morgan Stanley
- 07/07/22 Daiwa
- Merck upgraded to Outperform from Neutral at Daiwa (yesterday)
ATRA Atara Biotherapeutics - 07/20/22 Citi
- Atara Biotherapeutics downgraded to Sell from Neutral at Citi
- 07/13/22 Canaccord
- Atara Biotherapeutics price target lowered to $50 from $67 at Canaccord
- 07/13/22 Stifel
- Stifel downgrades Atara Biotherapeutics to Hold following ATA188 analysis
- 07/13/22 Stifel
- Atara Biotherapeutics downgraded to Hold from Buy at Stifel
- $104.93 /
+0.135 (+0.13%) - 07/20/22 BofA
- Arista double downgraded to Underperform at BofA on upcoming deterioration
- 07/20/22 BofA
- Arista Networks downgraded to Underperform from Buy at BofA
- 07/19/22 Needham
- Needham upgrades Arista Networks to Buy, sees the company as insulated
- 07/19/22 Needham
- Arista Networks upgraded to Buy from Hold at Needham
- 07/20/22 BofA
- Juniper double downgraded to Underperform at BofA on upcoming deterioration
- 07/20/22 BofA
- Juniper downgraded to Underperform from Buy at BofA
- 07/14/22 JPMorgan
- Juniper upgraded to Overweight from Neutral at JPMorgan
- 07/13/22 Evercore ISI
- Juniper added to 'Tactical Outperform' list at Evercore ISI
- $103.97 /
-0.775 (-0.74%) - 07/19/22 Bernstein
- Alibaba upgraded to Outperform from Market Perform at Bernstein
- 07/11/22 Goldman Sachs
- Pinduoduo grocery focus to drive sustained growth, says Goldman Sachs
- 07/11/22 Goldman Sachs
- Alibaba price target raised to $167 from $163 at Goldman Sachs
- 07/06/22 Benchmark
- Alibaba price target raised to $205 from $200 at Benchmark
- 07/20/22 Wolfe Research
- PayPal downgraded to Peer Perform from Outperform at Wolfe Research
- 07/20/22 Wells Fargo
- PayPal price target lowered to $97 from $115 at Wells Fargo
- 07/20/22 JPMorgan
- PayPal price target lowered to $112 from $127 at JPMorgan
- 07/15/22 RBC Capital
- PayPal price target lowered to $92 from $110 at RBC Capital
RYTM Rhythm Pharmaceuticals - 07/20/22 Stifel
- Rhythm Pharmaceuticals price target raised to $37 from $25 at Stifel
- 07/13/22 Ladenburg
- Rhythm Pharmaceuticals price target raised to $23 from $15 at Ladenburg
- 07/12/22 Goldman Sachs
- Rhythm Pharmaceuticals price target raised to $6 from $4 at Goldman Sachs
- 06/17/22 Needham
- Rhythm Pharmaceuticals price target lowered to $25 from $40 at Needham
- 07/19/22 Bernstein
- Bernstein starts Datadog at Outperform with $172 price target
- 07/19/22 Bernstein
- Datadog initiated with an Outperform at Bernstein
- 07/19/22 Mizuho
- Datadog price target lowered to $150 from $175 at Mizuho
- 07/07/22 Canaccord
- Datadog initiated with a Hold at Canaccord
- 05/19/22 B. Riley
- Vaxart price target lowered to $6 from $7 at B. Riley
- 02/28/22 Piper Sandler
- Piper Sandler 'impressed' by Vaxart's progress in COVID, norovirus programs
- 01/13/22 Piper Sandler
- Vaxart COVID booster on track for first half of the year, says Piper Sandler
- 12/29/21 Jefferies
- Vaxart assumed with a Buy at Jefferies
RVMD Revolution Medicines - 06/06/22 H.C. Wainwright
- Turning Point Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
- 05/20/22 BofA
- BofA starts Revolution Medicines at Neutral with $24 price target
- 05/20/22 BofA
- Revolution Medicines initiated with a Neutral at BofA
- 03/01/22 Stifel
- Stifel upgrades Revolution Medicines, sees good entry point after pullback
- 07/13/22 Exane BNP Paribas
- Vale downgraded to Neutral from Outperform at Exane BNP Paribas
- 06/29/22 Deutsche Bank
- Vale price target lowered to $20 from $22 at Deutsche Bank
- 06/22/22 Morgan Stanley
- Vale price target lowered to $16 from $22 at Morgan Stanley
- 06/07/22 Jefferies
- Vale upgraded to Buy from Hold at Jefferies
- 07/21/22 Citi
- Bath & Body Works price target lowered to $42 from $54 at Citi
- 07/20/22 Goldman Sachs
- Bath & Body Works price target lowered to $32 from $37 at Goldman Sachs
- 07/15/22 UBS
- Bath & Body Works price target lowered to $42 from $70 at UBS
- 07/13/22 Evercore ISI
- Evercore downgrades Bath & Body Works on reversion in consumer spending
- 07/21/22 Credit Suisse
- Nasdaq price target raised to $202 from $189 at Credit Suisse
- 07/13/22 Deutsche Bank
- Nasdaq price target lowered to $175 from $184 at Deutsche Bank
- 06/27/22 Jefferies
- Nasdaq price target lowered to $174 from $182 at Jefferies
- 05/19/22 Deutsche Bank
- Nasdaq price target lowered to $184 from $207 at Deutsche Bank
- 07/21/22 Credit Suisse
- Capri Holdings price target lowered to $56 from $65 at Credit Suisse
- 07/21/22 Goldman Sachs
- Capri Holdings price target lowered to $59 from $69 at Goldman Sachs
- 07/15/22 UBS
- Capri Holdings price target lowered to $65 from $91 at UBS
- 07/07/22 Wells Fargo
- Capri Holdings price target lowered to $70 from $85 at Wells Fargo
- 07/20/22 Stifel
- Badger Meter price target lowered to $79 from $88 at Stifel
- 07/18/22 Northcoast
- Badger Meter initiated with a Neutral at Northcoast (Friday)
- 04/20/22 Stifel
- Badger Meter price target lowered to $88 from $93 at Stifel
- 01/31/22 Stifel
- Badger Meter price target lowered to $93 from $103 at Stifel
- 07/21/22 Barclays
- Northern Trust price target lowered to $120 from $140 at Barclays
- 07/21/22 Credit Suisse
- Northern Trust price target lowered to $99 from $106 at Credit Suisse
- 07/13/22 Deutsche Bank
- Northern Trust price target lowered to $112 from $113 at Deutsche Bank
- 07/12/22 Citi
- Northern Trust price target lowered to $100 from $125 at Citi
- $61.60 /
+9.215 (+17.59%) - 07/21/22 RBC Capital
- New Relic price target raised to $62 from $45 at RBC Capital
- 07/18/22 Truist
- New Relic price target lowered to $80 from $85 at Truist
- 07/11/22 Morgan Stanley
- New Relic downgraded to Equal Weight from Overweight at Morgan Stanley
- 07/07/22 Canaccord
- New Relic initiated with a Buy at Canaccord
- 07/21/22 Nomura
- Ford upgraded to Neutral from Reduce at Nomura
- 07/21/22 Nomura
- Ford upgraded to Neutral from Reduce at Nomura
- 07/18/22 Deutsche Bank
- Ford price target lowered to $12 from $17 at Deutsche Bank
- 07/14/22 Morgan Stanley
- General Motors price target lowered to $42 from $44 at Morgan Stanley
- 05/10/22
- Wynn Resorts reports Q1 adjusted EPS ($1.21), consensus ($1.15)
- 05/10/22
- Notable companies reporting after market close
- 02/15/22
- Wynn Resorts reports Q4 EPS ($1.54), consensus ($1.25)
- 02/15/22
- Notable companies reporting after market close
- 05/09/22
- Vaxart reports Q1 EPS (20c), consensus (16c)
- 02/24/22
- Vaxart reports Q4 EPS (17c), consensus (17c)
- 04/28/22
- Vale reports Q1 EPS 93c, consensus 85c
- 02/24/22
- Vale reports Q4 EPS $1.07, consensus 83c
RYTM Rhythm Pharmaceuticals - 05/03/22
- Rhythm Pharmaceuticals reports Q1 EPS ($1.05), consensus ($1.01)
- 03/01/22
- Rhythm Pharmaceuticals sees Q4 EPS (85c), consensus (91c)
RVMD Revolution Medicines - 05/09/22
- Revolution Medicines sees FY22 GAAP net loss $260M-$290M
- 05/09/22
- Revolution Medicines reports Q1 EPS (78c), consensus (77c)
- 02/28/22
- Revolution Medicines reports Q3 EPS (71c), consensus (64c)
- 04/27/22
- PayPal sees Q2 adjusted EPS roughly 86c, consensus $1.12
- 04/27/22
- PayPal sees FY22 adjusted EPS $3.81-$3.93, consensus $4.63
- 04/27/22
- PayPal reports Q1 adjusted EPS 88c, consensus 88c
- 04/27/22
- Notable companies reporting after market close
- 07/20/22
- Northern Trust reports Q2 EPS $1.86, consensus $1.95
- 04/26/22
- Northern Trust reports Q1 EPS $1.77, consensus $1.64
- $216.46 /
+14.73 (+7.30%) - 07/19/22
- Netflix sees Q3 EPS $2.14, consensus $2.77
- 07/19/22
- Netflix reports Q2 EPS $3.20, consensus $2.96
- 07/19/22
- Notable companies reporting after market close
- 04/19/22
- Netflix sees Q2 EPS $3.00, consensus $3.01
- $61.60 /
+9.215 (+17.59%) - 05/12/22
- New Relic sees Q1 adjusted EPS (38c)-(35c), consensus (8c)
- 05/12/22
- New Relic sees FY23 adjusted EPS (37c)-(31c), consensus (10c)
- 05/12/22
- New Relic reports Q4 adjusted EPS (24c), consensus (21c)
- 05/12/22
- Notable companies reporting after market close
- 07/20/22
- Nasdaq reports Q2 adjusted EPS $2.07, consensus $1.93
- 04/20/22
- Nasdaq reports Q1 adjusted EPS $1.97, consensus $1.95
- 01/26/22
- Nasdaq reports Q4 adjusted EPS $1.93, consensus $1.77
- 04/28/22
- Merck raises FY22 adjusted EPS view to $7.24-$7.36, consensus $7.24
- 04/28/22
- Merck reports Q1 adjusted EPS $2.14, consensus $1.83
- 04/27/22
- Notable companies reporting before tomorrow's open
MLCO Melco Resorts & Entertainment - 05/05/22
- Melco Resorts & Entertainment reports Q1 EPS 38.8c vs 48.8c last year
- 03/01/22
- Melco Resorts & Entertainment reports Q4 EPS (11.2c) vs. (14c) last year
- 05/09/22
- IAC reports Q1 EPS ($2.72), consensus (75c)
- 05/02/22
- MGM Resorts reports Q1 adjusted EPS 1c, consensus (7c)
- 05/02/22
- Notable companies reporting after market close
- 02/09/22
- MGM Resorts reports Q4 adjusted EPS 12c, consensus 2c
- 07/20/22
- Las Vegas Sands reports Q2 adjusted property EBITDA $209M
- 07/20/22
- Las Vegas Sands reports Q2 adjusted cont ops EPS (34c), consensus (29c)
- 07/20/22
- Notable companies reporting after market close
- 04/27/22
- Las Vegas Sands reports Q1 consolidated adjusted property EBITDA $110M
- 04/26/22
- Juniper sees Q2 EPS 40c-50c, consensus 46c
- 04/26/22
- Juniper reports preliminary Q1 EPS 31c, consensus 32c
- 04/26/22
- Notable companies reporting after market close
- 01/27/22
- Juniper sees Q1 EPS 26c-36c, consensus 32c
- 06/28/22
- InterDigital raises Q2 revenue view to $120M-$124M from $114M-$120M
- 04/27/22
- Ford reports Q1 adjusted EPS 38c, consensus 37c
- 02/03/22
- Ford reports Q4 adjusted EPS 26c, consensus 45c
- 05/05/22
- Datadog sees FY22 adjusted EPS 70c-77c, consensus 52c
- 05/05/22
- Datadog sees Q2 adjusted EPS 13c-15c, consensus 12c
- 05/05/22
- Datadog reports Q1 adjusted EPS 24c, consensus 11c
- 05/04/22
- Notable companies reporting before tomorrow's open
- 07/20/22
- Capri Holdings backs FY23 EPS view $6.85, consensus $6.83
- 06/01/22
- Capri Holdings provides quarterly FY23 guidance
- 06/01/22
- Capri Holdings sees Q1 EPS $1.35, consensus $1.45
- 06/01/22
- Capri Holdings sees FY23 EPS $6.85, consensus $6.57
- 07/20/22
- Badger Meter reports Q2 EPS 57c, consensus 51c
- 04/19/22
- Badger Meter reports Q1 EPS 49c, consensus 51c
- 01/28/22
- Badger Meter reports Q4 EPS 59c, consensus 47c
- 07/20/22
- Baker Hughes reports Q2 EPS 11c, consensus 22c
- 04/20/22
- Baker Hughes reports Q1 EPS 15c, consensus 19c
- 04/20/22
- Baker Hughes reports Q1 adjusted EPS 15c, consensus 19c
- 04/19/22
- Notable companies reporting before tomorrow's open
- $207.57 /
-12.745 (-5.78%) - 07/20/22
- Biogen raises FY22 adjusted EPS view to $15.25-$16.75, consensus $15.54
- 07/20/22
- Biogen reports Q2 adjusted EPS $5.25, consensus $4.10
- 07/20/22
- Bath & Body Works lowers 2022 sales view to down mid to high single digits
- 07/20/22
- Bath & Body Works lowers Q2 EPS view 40c-42c from 60c-65c, consensus 62c
- 05/19/22
- Bath & Body Works sees FY sales up low single digits, consensus $7.72B
- 05/19/22
- Bath & Body Works sees Q2 sales up low single digits, consensus $1.65B
- $103.97 /
-0.775 (-0.74%) - 05/26/22
- Alibaba reports Q4 EPS $1.25, consensus $1.10
- 05/25/22
- Notable companies reporting before tomorrow's open
- 02/24/22
- Alibaba reports Q4 EPS $2.65, consensus $2.55
- 04/27/22
- Boeing reports Q1 core EPS ($2.75), consensus (12c)
- 04/26/22
- Notable companies reporting before tomorrow's open
- 04/11/22
- Ultra Clean cuts Q1 revenue view to $560M-$570M from $580M-$630M
ATRA Atara Biotherapeutics - 05/05/22
- Atara Biotherapeutics reports Q1 EPS (87c), consensus (98c)
- 02/28/22
- Atara Biotherapeutics reports Q4 EPS (96c), consensus (69c)
- $104.93 /
+0.135 (+0.13%) - 05/02/22
- Arista Networks sees Q2 revenue $950M-$1.0B, consensus $917.8M
- 05/02/22
- Arista Networks reports Q1 EPS 84c, consensus 81c
- 02/14/22
- Arista Networks sees Q1 revenue $840M-$860M, consensus $831.58M
- 07/20/22
- Abbott raises FY22 adjusted EPS view to at least $4.90 from at least $4.70
- 07/20/22
- Abbott reports Q2 adjusted EPS $1.43, consensus $1.12
- 07/19/22
- Notable companies reporting before tomorrow's open
- 04/28/22
- Apple says y/y Q3 revenue growth to be impacted by COVID
- 04/28/22
- Apple reports Q2 EPS $1.52, consensus $1.43
- 04/28/22
- Notable companies reporting after market close
- 02/27/22
- Berkshire operating earnings surge, Buffett repurchases record $27B in stock
|